Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 14, keine Gesamtzahl für „Table“
Suchtreffer
Begriffe & Kennungen
Buvidal · 4.8 · 11 Table 2. Adverse reactions listed by body system System Organ Class Very common Common Uncommon Not known
Eintrag öffnenBuvidal · 4.8 · 26 Table 2. Adverse reactions listed by body system System Organ Class Very common Common Uncommon Not known
Eintrag öffnenBuvidal · 4.8 · Table 2 presents adverse reactions reported for buprenorphine, including Buvidal. The following terms and freq
Eintrag öffnenBuvidal · 4.8 · Table 2 presents adverse reactions reported for buprenorphine, including Buvidal. The following terms and freq
Eintrag öffnenBuvidal · 4.8 · Table 2. Adverse reactions listed by body system System Organ Class Very common Common Uncommon Not known
Eintrag öffnenBuvidal · 4.8 · Table 2. Adverse reactions listed by body system System Organ Class Very common Common Uncommon Not known
Eintrag öffnenCabazitaxel Accord · 4.8 · Table 2: Reported adverse reactions and haematological abnormalities with cabazitaxel in combination with pred
Eintrag öffnenCabazitaxel Accord · 4.8 · Tabulated list of adverse reactions Adverse reactions are listed in table 2 according to MedDRA system organ c
Eintrag öffnenCablivi · 4.8 · 5 Table 1 . List of adverse reactions in TITAN and HERCULES studies
Eintrag öffnenCabometyx · 4.8 · Table 2: Adverse drug reactions (ADRs) reported in clinical trials or after post-marketing use in patients tre
Eintrag öffnenCabometyx · 4.8 · Table 3: Adverse reactions with cabozantinib in combination with nivolumab Infections and infestations Very Co
Eintrag öffnenCaelyx pegylated liposomal · 4.8 · Table 5: Adverse reactions in patients treated with Caelyx pegylated liposomal System Organ Class Frequency Al
Eintrag öffnenCaelyx pegylated liposomal · 4.8 · Tabulated list of adverse reactions Table 5 summarises the adverse drug reactions that occurred in patients re
Eintrag öffnenCalquence · 4.8 · Table 4. Adverse drug reactions* of patients with haematological malignancies treated with acalabrutinib monot
Eintrag öffnenCalquence · 4.8 · Table 4. Adverse drug reactions* of patients with haematological malignancies treated with acalabrutinib monot
Eintrag öffnenCalquence · 4.8 · Table 5. Adverse drug reactions* of patients with haematological malignancies treated with acalabrutinib combi
Eintrag öffnenCalquence · 4.8 · Table 5. Adverse drug reactions* of patients with haematological malignancies treated with acalabrutinib combi
Eintrag öffnenCalquence · 4.8 · The below tables present adverse drug reactions (ADRs) identified in clinical studies with patients receiving
Eintrag öffnenCalquence · 4.8 · The below tables present adverse drug reactions (ADRs) identified in clinical studies with patients receiving
Eintrag öffnenCamzyos · 4.5 · 10 Table 2: Dose modification/monitoring of mavacamten with concomitant medicinal products
Eintrag öffnen